Renaissance Capital logo

G Medical Innovations Holdings Filed Terms, Nasdaq: GMVD

Provides app-connected medical devices for monitoring vital signs.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

We are an early commercial stage healthcare company engaged in the development of next generation mobile health (or mHealth) and telemedicine solutions and monitoring service platforms. We believe we are at the forefront of the digital health revolution in developing the next generation mobile technologies and services that are designed to empower consumers, patients and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease and diabetes. Using our proprietary and patented suite of devices, software solutions, algorithms and monitoring services, we intend to drive recurring revenue streams in two vertical markets, with a focus on markets in the United States and China as well as other markets. Our management team is led by individuals with over 30 years of combined experience in developing mobile embedded medical sensors, and with over 48 medical devices approved by FDA, including devices approved when the members of our management team were employed at other companies. Our management has proven their ability to execute our go-to-market strategy, with over 25 years of medical device development and commercialization experience.
more less
IPO News for G Medical Innovations Holdings
more
IPO Data
IPO File Date 03/04/2021
Offer Price
Price Range $5.00 - $7.00
Offer Shares (mm) 3.0
Deal Size ($mm) $18
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $5.00 - $7.00
Offer Shares (mm) 3.0
Deal Size ($mm) $18
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Rehovot, Israel
Founded 2014
Employees 74
Website gmedinnovations.com